Dr Elinor Hortle
Postdoctoral Research Fellow, Lab Head and Faculty
Dr. Elinor Hortle received her PhD in 2015 studying the genetics of resistance to malaria. She joined the Centenary institute in 2017 to study innate immune responses and host-directed therapies for mycobacterial disease. In 2019 she won the national Bayer Innovation Award for her discovery that anti-platelet drugs could be used to treat mycobacterial infection. In 2021 she began studying both infectious and non-infectious respiratory diseases including COPD and pseudomonas aeruginosa infection. Dr Hortle’s overarching goal is to understand the fundamental interactions between innate immunity and respiratory pathogens / environmental insults, with a strong emphasis on identifying novel therapeutic strategies.
